Company intelligence / Profile preview

Notch Therapeutics

Vancouver, British Columbia, Canadanotchtx.com ↗

Ownership: Private
Employees: ~100
Development stage: Preclinical

Overview

Their CD19 CAR UNi-T Cells have shown promising results in pre-clinical studies, eliminating tumors within the first week of study and maintaining complete tumor remission in animal models.

Therapeutic areas: OncologyHematology
Modalities: Cell therapy
Industry: Biotech

Partnerships

Actively pursuing industry partnerships

Beyond the preview

Go deeper on Notch Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Notch Therapeutics.